[Des-Asp1]-Angiotensin I, human lacks the N-terminal aspartate, offering a clean system to study processing and regional contributions to conformation. Removal of the initial residue influences peptide charge distribution and enzymatic recognition. This variant is used to examine precursor activation pathways and substrate specificity. Its stability and clarity make it a staple in synthetic and regulatory pathway research.
CAT No: A15017
1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
2. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More